866-997-4948(US-Canada Toll Free)

Global Nuclear Medicine/Radiopharmaceutic Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 126 Pages

This report studies the global market size of Nuclear Medicine/Radiopharmaceutic in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nuclear  medicine/Radiopharmaceutic in these regions.

This research report categorizes the global Nuclear Medicine/Radiopharmaceutic market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Nuclear Medicine/Radiopharmaceutic market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Nuclear Medicine/Radiopharmaceutic market based on company, product type, application and key regions.

The various contributors involved in the value chain of Nuclear Medicine/Radiopharmaceutic include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Nuclear Medicine/Radiopharmaceutic include
China Isotope Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Cardinal Health
Mallinckrodt
GE Healthcare
Lantheus Medical Imaging
Bayer Healthcare
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
Iba Molecular Imaging

Market Size Split by Type
Diagnostic
Therapeutic

Market Size Split by Application
Oncology
Thyroid
Cardiology
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Nuclear Medicine/Radiopharmaceutic market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Nuclear Medicine/Radiopharmaceutic market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Nuclear Medicine/Radiopharmaceutic manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nuclear Medicine/Radiopharmaceutic with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Nuclear Medicine/Radiopharmaceutic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nuclear Medicine/Radiopharmaceutic are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nuclear Medicine/Radiopharmaceutic market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Nuclear Medicine/Radiopharmaceutic Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type
1.4.2 Diagnostic
1.4.3 Therapeutic
1.5 Market by Application
1.5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Thyroid
1.5.4 Cardiology
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size
2.1.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2016-2025
2.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2016-2025
2.2 Nuclear Medicine/Radiopharmaceutic Growth Rate by Regions
2.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Regions
2.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers
3.1.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers
3.1.2 Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers
3.1.3 Global Nuclear Medicine/Radiopharmaceutic Market Concentration Ratio (CR5 and HHI)
3.2 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers
3.2.1 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2016-2018)
3.2.2 Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2016-2018)
3.3 Nuclear Medicine/Radiopharmaceutic Price by Manufacturers
3.4 Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceutic Product Category
3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Type
4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Type
4.3 Nuclear Medicine/Radiopharmaceutic Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Nuclear Medicine/Radiopharmaceutic Breakdown Data by Application

6 North America
6.1 North America Nuclear Medicine/Radiopharmaceutic by Countries
6.1.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Countries
6.1.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Nuclear Medicine/Radiopharmaceutic by Type
6.3 North America Nuclear Medicine/Radiopharmaceutic by Application
6.4 North America Nuclear Medicine/Radiopharmaceutic by Company

7 Europe
7.1 Europe Nuclear Medicine/Radiopharmaceutic by Countries
7.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Countries
7.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nuclear Medicine/Radiopharmaceutic by Type
7.3 Europe Nuclear Medicine/Radiopharmaceutic by Application
7.4 Europe Nuclear Medicine/Radiopharmaceutic by Company

8 Asia Pacific
8.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Countries
8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Countries
8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Type
8.3 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Application
8.4 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Company

9 Central & South America
9.1 Central & South America Nuclear Medicine/Radiopharmaceutic by Countries
9.1.1 Central & South America Nuclear Medicine/Radiopharmaceutic Sales by Countries
9.1.2 Central & South America Nuclear Medicine/Radiopharmaceutic Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Nuclear Medicine/Radiopharmaceutic by Type
9.3 Central & South America Nuclear Medicine/Radiopharmaceutic by Application
9.4 Central & South America Nuclear Medicine/Radiopharmaceutic by Company

10 Middle East and Africa
10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Countries
10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Countries
10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Type
10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Application
10.4 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Company

11 Company Profiles
11.1 China Isotope Radiation
11.1.1 China Isotope Radiation Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceutic
11.1.4 Nuclear Medicine/Radiopharmaceutic Product Description
11.1.5 Recent Development
11.2 Dongcheng
11.2.1 Dongcheng Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceutic
11.2.4 Nuclear Medicine/Radiopharmaceutic Product Description
11.2.5 Recent Development
11.3 Jaco
11.3.1 Jaco Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceutic
11.3.4 Nuclear Medicine/Radiopharmaceutic Product Description
11.3.5 Recent Development
11.4 Ciaeriar
11.4.1 Ciaeriar Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceutic
11.4.4 Nuclear Medicine/Radiopharmaceutic Product Description
11.4.5 Recent Development
11.5 Advanced Molecular-imaging Solution
11.5.1 Advanced Molecular-imaging Solution Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceutic
11.5.4 Nuclear Medicine/Radiopharmaceutic Product Description
11.5.5 Recent Development
11.6 Shanghai Atom Kexing
11.6.1 Shanghai Atom Kexing Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceutic
11.6.4 Nuclear Medicine/Radiopharmaceutic Product Description
11.6.5 Recent Development
11.7 Cardinal Health
11.7.1 Cardinal Health Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceutic
11.7.4 Nuclear Medicine/Radiopharmaceutic Product Description
11.7.5 Recent Development
11.8 Mallinckrodt
11.8.1 Mallinckrodt Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceutic
11.8.4 Nuclear Medicine/Radiopharmaceutic Product Description
11.8.5 Recent Development
11.9 GE Healthcare
11.9.1 GE Healthcare Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceutic
11.9.4 Nuclear Medicine/Radiopharmaceutic Product Description
11.9.5 Recent Development
11.10 Lantheus Medical Imaging
11.10.1 Lantheus Medical Imaging Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceutic
11.10.4 Nuclear Medicine/Radiopharmaceutic Product Description
11.10.5 Recent Development
11.11 Bayer Healthcare
11.12 Bracco Imaging
11.13 Eczacibasi-Monrol Nuclear Products
11.14 Nordion
11.15 Advanced Accelerator Applications
11.16 Iba Molecular Imaging
11.31 China
11.32 China
11.33 China
11.34 China
11.35 China
11.36 China
11.37 Europe
11.38 Europe
11.39 Europe
11.40 Europe

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Nuclear Medicine/Radiopharmaceutic Raw Material
13.1.2 Nuclear Medicine/Radiopharmaceutic Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Nuclear Medicine/Radiopharmaceutic
Figure Global Nuclear Medicine/Radiopharmaceutic Production (MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Production Market Share by Types (Product Category) in 2017
Figure Diagnostic Product Picture
Table Major Manufacturers of Diagnostic
Figure Therapeutic Product Picture
Table Major Manufacturers of Therapeutic
Table Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Application 2018-2025 (MT)
Figure Oncology
Figure Thyroid
Figure Cardiology
Figure Others
Figure Nuclear Medicine/Radiopharmaceutic Report Years Considered
Figure Global Nuclear Medicine/Radiopharmaceutic Market Size 2016-2025 (Million US$)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales 2016-2025 (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Market Size by Regions 2016-2025 (MT) & (Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Regions 2016-2025 (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions 2016-2025
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions 2016-2025
Figure 2017 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions
Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions 2016-2025 (Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions 2016-2025
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions 2016-2025
Figure 2017 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers (2016-2018) (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers (2016-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers in 2017
Table Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2016-2018) (Million US$)
Table Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2016-2018)
Figure Nuclear Medicine/Radiopharmaceutic Value Share by Manufacturers in 2017
Table Global Nuclear Medicine/Radiopharmaceutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Nuclear Medicine/Radiopharmaceutic Price (2016-2018) (USD/Kg)
Table Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Nuclear Medicine/Radiopharmaceutic Product Category
Table Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2025) (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2016-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2017
Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2016-2025) (Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2016-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2016-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type in 2017
Table Nuclear Medicine/Radiopharmaceutic Price by Type 2013-2018 (USD/Kg)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2025) (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2016-2025)
Figure Global Sales Nuclear Medicine/Radiopharmaceutic Market Share by Application (2016-2025)
Figure Global Sales Nuclear Medicine/Radiopharmaceutic Market Share by Application (2016-2025)
Figure North America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2016-2025 (MT)
Figure North America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2016-2025 (Million US$)
Table North America Nuclear Medicine/Radiopharmaceutic Sales by Countries (2016-2025) (MT)
Table North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2016-2025)
Figure 2017 North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries
Table North America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2016-2025) (Million US$)
Table North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure United States Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Canada Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Mexico Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Table North America Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2025) (MT)
Table North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2025)
Figure 2017 North America Nuclear Medicine/Radiopharmaceutic Market Share by Type
Table North America Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2025) (MT)
Table North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2025)
Figure 2017 North America Nuclear Medicine/Radiopharmaceutic Market Share by Application
Table North America Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2018) (MT)
Table North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2018)
Figure North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2017
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2016-2025 (MT)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales by Countries (2016-2025) (MT)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries
Table Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2016-2025) (Million US$)
Table Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries
Figure Germany Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Germany Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (MT)
Figure France Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure France Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (MT)
Figure UK Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure UK Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Italy Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Russia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2025) (MT)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2025)
Figure 2017 Europe Nuclear Medicine/Radiopharmaceutic Market Share by Type
Table Europe Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2025) (MT)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2025)
Figure 2017 Europe Nuclear Medicine/Radiopharmaceutic Market Share by Application
Table Europe Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2018) (MT)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2018)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2017
Figure Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2016-2025 (MT)
Figure Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Countries (2016-2025) (MT)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries
Figure China Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Korea Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure India Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure India Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Australia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Indonesia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Malaysia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Philippines Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Thailand Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Vietnam Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Singapore Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2025) (MT)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Share by Type
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2025) (MT)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Share by Application
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2018) (MT)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2018)
Figure Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2017
Figure Central & South America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2016-2025 (MT)
Figure Central & South America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales by Countries (2016-2025) (MT)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries
Table Central & South America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries
Figure Brazil Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Brazil Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Argentina Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2025) (MT)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Nuclear Medicine/Radiopharmaceutic Market Share by Type
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2025) (MT)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Nuclear Medicine/Radiopharmaceutic Market Share by Application
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2018) (MT)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2018)
Figure Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2017
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2016-2025 (MT)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Countries (2016-2025) (MT)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries
Figure GCC Countries Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure GCC Countries Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Turkey Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure Egypt Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2025) (MT)
Figure South Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2025) (MT)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Share by Type
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2025) (MT)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Share by Application
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2018) (MT)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2017
Table China Isotope Radiation Company Details
Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table China Isotope Radiation Recent Development
Table Dongcheng Company Details
Table Dongcheng Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Dongcheng Recent Development
Table Jaco Company Details
Table Jaco Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Jaco Recent Development
Table Ciaeriar Company Details
Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Ciaeriar Recent Development
Table Advanced Molecular-imaging Solution Company Details
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Advanced Molecular-imaging Solution Recent Development
Table Shanghai Atom Kexing Company Details
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Shanghai Atom Kexing Recent Development
Table Cardinal Health Company Details
Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Cardinal Health Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Mallinckrodt Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table GE Healthcare Recent Development
Table Lantheus Medical Imaging Company Details
Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Lantheus Medical Imaging Recent Development
Table Bayer Healthcare Company Details
Table Bracco Imaging Company Details
Table Eczacibasi-Monrol Nuclear Products Company Details
Table Nordion Company Details
Table Advanced Accelerator Applications Company Details
Table Iba Molecular Imaging Company Details
Table China Company Details
Table China Company Details
Table China Company Details
Table China Company Details
Table China Company Details
Table China Company Details
Table Europe Company Details
Table Europe Company Details
Table Europe Company Details
Table Europe Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Nuclear Medicine/Radiopharmaceutic Value Chain
Table Typical Suppliers of Key Nuclear Medicine/Radiopharmaceutic Raw Material
Table Nuclear Medicine/Radiopharmaceutic Customers List
Table Nuclear Medicine/Radiopharmaceutic Sales Channels
Table Nuclear Medicine/Radiopharmaceutic Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *